abs53.txt	objective		to	evaluate	the	natural	history	of	treated	and	untreated	cervicalintraepithelial	neoplasia-2	(cin2)	among	hiv-positive	women	methods		participants	were	women	enrolled	in	the	women's	interagency	hiv	studybetween	1994	and	2013		104	hiv-positive	women	diagnosed	with	cin2	before	age	46were	selected		contributing	2	076	visits	over	a	median	of	10	years	(iqr	5-16)	the	outcome	of	interest	was	biopsy-confirmed	cin2	progression		defined	as	cin3	orinvasive	cervical	cancer		cin2	treatment	was	abstracted	from	medical	records	results		the	majority	of	women	were	african	american	(53%)		current	smokers	(53%)and	had	a	median	age	of	33	years	at	cin2	diagnosis		among	the	104	hiv-positivewomen		62	(59	6%)	did	not	receive	cin2	treatment		twelve	hiv-positive	women(11	5%)	showed	cin2	progression	to	cin3		none	were	diagnosed	with	cervicalcancer		there	was	no	difference	in	the	median	time	to	progression	betweencin2-treated	and	-untreated	hiv-positive	women	(2	9	vs		2	7	years		p=0	41)		cin2treatment	was	not	associated	with	cin2	progression	in	multivariate	analysis	(ahr[adjusted	hazard	ratio]	1	82		95%	ci	[confidence	interval]	0	54		7	11)		adjustingfor	combination	antiretroviral	therapy	(cart)	and	cd4+	t	cell	count		inhiv-positive	women		each	increase	of	100	cd4+	t	cells	was	associated	with	a	33%decrease	in	cin2	progression	(ahr	0	67		95%	ci	0	47		0	88)		adjusting	for	cin2treatment	and	cart	conclusions		cin2	progression	is	uncommon	in	this	population		regardless	of	cin2treatment		additional	studies	are	needed	to	identify	factors	to	differentiatewomen	at	highest	risk	of	cin2	progression	
